Daniel Irimia, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neutrophils | 68 | 2024 | 3724 | 9.740 |
Why?
|
| Microfluidic Analytical Techniques | 52 | 2021 | 812 | 7.560 |
Why?
|
| Chemotaxis | 22 | 2023 | 593 | 5.800 |
Why?
|
| Microfluidics | 35 | 2023 | 655 | 5.670 |
Why?
|
| Chemotaxis, Leukocyte | 19 | 2023 | 661 | 4.140 |
Why?
|
| Cell Movement | 37 | 2024 | 5172 | 3.660 |
Why?
|
| Chemotactic Factors | 9 | 2022 | 191 | 2.930 |
Why?
|
| Lab-On-A-Chip Devices | 7 | 2023 | 428 | 1.970 |
Why?
|
| Aspergillus fumigatus | 4 | 2024 | 156 | 1.780 |
Why?
|
| Sepsis | 8 | 2023 | 2588 | 1.650 |
Why?
|
| Burns | 10 | 2018 | 1854 | 1.500 |
Why?
|
| Leukocytes | 8 | 2019 | 2028 | 1.380 |
Why?
|
| Docosahexaenoic Acids | 7 | 2018 | 899 | 1.230 |
Why?
|
| Spheroids, Cellular | 2 | 2021 | 329 | 1.210 |
Why?
|
| Megakaryocytes | 2 | 2023 | 560 | 1.150 |
Why?
|
| Aspergillosis | 3 | 2024 | 242 | 1.110 |
Why?
|
| Microinjections | 2 | 2017 | 321 | 1.100 |
Why?
|
| Candida albicans | 6 | 2022 | 373 | 1.080 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 5 | 2018 | 220 | 1.050 |
Why?
|
| Staphylococcus aureus | 4 | 2022 | 1452 | 0.920 |
Why?
|
| Blood | 3 | 2019 | 584 | 0.880 |
Why?
|
| tau Proteins | 5 | 2021 | 2053 | 0.840 |
Why?
|
| Complement C5a | 3 | 2021 | 100 | 0.820 |
Why?
|
| Hyphae | 3 | 2021 | 52 | 0.800 |
Why?
|
| Nipecotic Acids | 1 | 2021 | 36 | 0.790 |
Why?
|
| Complement Inactivating Agents | 1 | 2021 | 51 | 0.790 |
Why?
|
| Interleukin-8 | 4 | 2018 | 701 | 0.760 |
Why?
|
| Actinomyces | 1 | 2021 | 40 | 0.750 |
Why?
|
| Antibiosis | 1 | 2021 | 45 | 0.740 |
Why?
|
| Glutamine | 1 | 2023 | 573 | 0.730 |
Why?
|
| Streptococcus | 1 | 2021 | 197 | 0.720 |
Why?
|
| Host-Pathogen Interactions | 2 | 2020 | 1439 | 0.710 |
Why?
|
| Leukocyte Disorders | 2 | 2022 | 13 | 0.710 |
Why?
|
| Cell Separation | 9 | 2016 | 1719 | 0.710 |
Why?
|
| Phagocytosis | 10 | 2024 | 1527 | 0.690 |
Why?
|
| Blood Platelets | 3 | 2023 | 2498 | 0.690 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2021 | 252 | 0.690 |
Why?
|
| Complement Activation | 1 | 2021 | 444 | 0.690 |
Why?
|
| Deoxyribonucleases | 2 | 2018 | 213 | 0.680 |
Why?
|
| Fungi | 2 | 2021 | 332 | 0.680 |
Why?
|
| Neutrophil Infiltration | 2 | 2020 | 389 | 0.670 |
Why?
|
| High-Throughput Screening Assays | 4 | 2018 | 929 | 0.670 |
Why?
|
| Zebrafish | 5 | 2019 | 2995 | 0.660 |
Why?
|
| Borrelia burgdorferi | 1 | 2021 | 182 | 0.660 |
Why?
|
| Tissue Array Analysis | 2 | 2018 | 550 | 0.650 |
Why?
|
| Models, Biological | 8 | 2020 | 9449 | 0.620 |
Why?
|
| Cell Communication | 6 | 2020 | 1632 | 0.620 |
Why?
|
| Candidiasis | 4 | 2022 | 357 | 0.620 |
Why?
|
| Colloids | 1 | 2018 | 124 | 0.620 |
Why?
|
| Tretinoin | 1 | 2021 | 522 | 0.600 |
Why?
|
| Inflammation | 17 | 2022 | 10696 | 0.590 |
Why?
|
| Dictyostelium | 2 | 2017 | 71 | 0.560 |
Why?
|
| Amyloid beta-Peptides | 6 | 2021 | 3807 | 0.560 |
Why?
|
| Time-Lapse Imaging | 4 | 2020 | 194 | 0.550 |
Why?
|
| Hepatic Insufficiency | 1 | 2016 | 13 | 0.550 |
Why?
|
| Alzheimer Disease | 10 | 2023 | 8433 | 0.550 |
Why?
|
| Cell Migration Assays, Leukocyte | 1 | 2016 | 8 | 0.540 |
Why?
|
| Biofilms | 1 | 2021 | 617 | 0.540 |
Why?
|
| Aniline Compounds | 1 | 2021 | 1056 | 0.540 |
Why?
|
| Rats, Wistar | 5 | 2018 | 1838 | 0.520 |
Why?
|
| Streptavidin | 1 | 2015 | 82 | 0.520 |
Why?
|
| Biological Assay | 2 | 2018 | 631 | 0.510 |
Why?
|
| HL-60 Cells | 6 | 2021 | 364 | 0.510 |
Why?
|
| Cytoplasm | 1 | 2020 | 1521 | 0.500 |
Why?
|
| Humans | 132 | 2024 | 752411 | 0.490 |
Why?
|
| Lyme Disease | 1 | 2021 | 630 | 0.490 |
Why?
|
| Biotin | 1 | 2015 | 253 | 0.480 |
Why?
|
| Organoids | 2 | 2018 | 716 | 0.480 |
Why?
|
| Dystonia Musculorum Deformans | 2 | 2014 | 158 | 0.470 |
Why?
|
| Cells, Cultured | 17 | 2021 | 18915 | 0.470 |
Why?
|
| Equipment Design | 12 | 2018 | 3511 | 0.450 |
Why?
|
| Erythrocytes | 8 | 2023 | 2401 | 0.430 |
Why?
|
| Models, Immunological | 1 | 2015 | 505 | 0.430 |
Why?
|
| Microchemistry | 3 | 2008 | 55 | 0.420 |
Why?
|
| Capillaries | 1 | 2016 | 744 | 0.420 |
Why?
|
| Immune System | 1 | 2018 | 796 | 0.420 |
Why?
|
| Cryopreservation | 4 | 2011 | 711 | 0.420 |
Why?
|
| Cytoskeleton | 7 | 2019 | 1168 | 0.410 |
Why?
|
| Immune System Diseases | 1 | 2014 | 258 | 0.410 |
Why?
|
| Blood Chemical Analysis | 2 | 2016 | 433 | 0.400 |
Why?
|
| Interleukin-1 | 1 | 2015 | 1249 | 0.390 |
Why?
|
| Epithelial Cells | 3 | 2014 | 3668 | 0.380 |
Why?
|
| Internationality | 1 | 2016 | 988 | 0.360 |
Why?
|
| Myosin Type II | 2 | 2021 | 69 | 0.360 |
Why?
|
| Cell Migration Assays | 2 | 2012 | 22 | 0.350 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2014 | 726 | 0.350 |
Why?
|
| Single-Cell Analysis | 2 | 2018 | 2318 | 0.350 |
Why?
|
| Renal Insufficiency | 1 | 2016 | 810 | 0.350 |
Why?
|
| Brain | 6 | 2021 | 26659 | 0.350 |
Why?
|
| T-Lymphocytes | 4 | 2015 | 10035 | 0.340 |
Why?
|
| Cell Line | 13 | 2023 | 15634 | 0.340 |
Why?
|
| Histones | 1 | 2020 | 2567 | 0.340 |
Why?
|
| Cytokines | 8 | 2021 | 7235 | 0.340 |
Why?
|
| Immunity, Innate | 7 | 2023 | 3029 | 0.330 |
Why?
|
| Blood-Brain Barrier | 1 | 2015 | 1014 | 0.330 |
Why?
|
| Epidermal Growth Factor | 1 | 2012 | 691 | 0.330 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2013 | 484 | 0.320 |
Why?
|
| Neurons | 7 | 2023 | 9353 | 0.320 |
Why?
|
| Gene Expression Profiling | 7 | 2018 | 9356 | 0.310 |
Why?
|
| Serum | 1 | 2009 | 212 | 0.310 |
Why?
|
| Electronics | 1 | 2009 | 316 | 0.300 |
Why?
|
| Signal Transduction | 14 | 2024 | 23234 | 0.300 |
Why?
|
| Neoplasms | 7 | 2023 | 21806 | 0.300 |
Why?
|
| Drug Delivery Systems | 1 | 2019 | 2213 | 0.290 |
Why?
|
| Ice | 3 | 2004 | 102 | 0.290 |
Why?
|
| Lipoxins | 3 | 2015 | 417 | 0.290 |
Why?
|
| Lipid Metabolism | 1 | 2015 | 1894 | 0.290 |
Why?
|
| Animals | 46 | 2022 | 166811 | 0.290 |
Why?
|
| Leukocyte Count | 2 | 2018 | 1590 | 0.280 |
Why?
|
| Nucleic Acid Amplification Techniques | 2 | 2008 | 329 | 0.280 |
Why?
|
| Gene Expression | 3 | 2018 | 7580 | 0.280 |
Why?
|
| Cell Line, Tumor | 16 | 2024 | 16737 | 0.280 |
Why?
|
| Larva | 3 | 2017 | 512 | 0.280 |
Why?
|
| Rats | 8 | 2018 | 23563 | 0.280 |
Why?
|
| Reactive Oxygen Species | 4 | 2024 | 2085 | 0.280 |
Why?
|
| Microglia | 3 | 2019 | 1322 | 0.270 |
Why?
|
| Blood Preservation | 2 | 2017 | 168 | 0.260 |
Why?
|
| Cryoprotective Agents | 2 | 2021 | 125 | 0.260 |
Why?
|
| Leukotriene B4 | 3 | 2021 | 281 | 0.260 |
Why?
|
| Cerebrovascular Circulation | 1 | 2015 | 2708 | 0.250 |
Why?
|
| Antifungal Agents | 2 | 2021 | 711 | 0.250 |
Why?
|
| Exosomes | 1 | 2009 | 422 | 0.250 |
Why?
|
| Micromanipulation | 1 | 2005 | 52 | 0.250 |
Why?
|
| Systemic Inflammatory Response Syndrome | 4 | 2022 | 616 | 0.240 |
Why?
|
| Eukaryotic Cells | 1 | 2006 | 195 | 0.240 |
Why?
|
| Monocytes | 3 | 2022 | 2556 | 0.240 |
Why?
|
| Fibroblasts | 2 | 2014 | 4058 | 0.240 |
Why?
|
| Membranes, Artificial | 1 | 2006 | 366 | 0.230 |
Why?
|
| Clinical Laboratory Techniques | 2 | 2011 | 744 | 0.230 |
Why?
|
| RNA | 5 | 2011 | 2700 | 0.230 |
Why?
|
| Eicosapentaenoic Acid | 3 | 2015 | 610 | 0.230 |
Why?
|
| Wounds and Injuries | 2 | 2015 | 2427 | 0.220 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2024 | 4341 | 0.220 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2024 | 255 | 0.220 |
Why?
|
| Cells | 1 | 2004 | 164 | 0.220 |
Why?
|
| Cell Size | 3 | 2018 | 621 | 0.220 |
Why?
|
| Cell-Derived Microparticles | 2 | 2016 | 161 | 0.220 |
Why?
|
| Skin | 5 | 2021 | 4426 | 0.220 |
Why?
|
| Blood Cell Count | 3 | 2019 | 398 | 0.210 |
Why?
|
| Nonmuscle Myosin Type IIA | 1 | 2022 | 28 | 0.210 |
Why?
|
| Candida | 2 | 2021 | 165 | 0.210 |
Why?
|
| Mitochondria | 2 | 2013 | 3556 | 0.210 |
Why?
|
| Complement C3-C5 Convertases | 1 | 2021 | 30 | 0.200 |
Why?
|
| Microarray Analysis | 2 | 2020 | 752 | 0.200 |
Why?
|
| Basidiomycota | 1 | 2021 | 17 | 0.200 |
Why?
|
| Equipment and Supplies | 1 | 2004 | 275 | 0.200 |
Why?
|
| Plaque, Amyloid | 2 | 2018 | 747 | 0.200 |
Why?
|
| Cell Aggregation | 3 | 2021 | 239 | 0.200 |
Why?
|
| G-Protein-Coupled Receptor Kinase 2 | 1 | 2021 | 9 | 0.200 |
Why?
|
| P-Selectin | 3 | 2016 | 601 | 0.200 |
Why?
|
| Cell Culture Techniques | 4 | 2018 | 1660 | 0.200 |
Why?
|
| Staphylococcal Infections | 2 | 2022 | 1402 | 0.200 |
Why?
|
| Biological Phenomena | 1 | 2021 | 28 | 0.190 |
Why?
|
| Receptor, Anaphylatoxin C5a | 1 | 2021 | 87 | 0.190 |
Why?
|
| Necrosis | 2 | 2018 | 1601 | 0.190 |
Why?
|
| Neoplastic Cells, Circulating | 5 | 2017 | 935 | 0.190 |
Why?
|
| Complement C5 | 1 | 2021 | 105 | 0.190 |
Why?
|
| Cell Polarity | 4 | 2021 | 636 | 0.190 |
Why?
|
| Ascomycota | 1 | 2021 | 82 | 0.190 |
Why?
|
| Neutrophil Activation | 1 | 2021 | 181 | 0.190 |
Why?
|
| Inflammation Mediators | 3 | 2016 | 1873 | 0.190 |
Why?
|
| Nanostructures | 1 | 2006 | 547 | 0.180 |
Why?
|
| Nanotechnology | 3 | 2012 | 704 | 0.180 |
Why?
|
| Tauopathies | 2 | 2018 | 313 | 0.180 |
Why?
|
| Cryoelectron Microscopy | 1 | 2004 | 628 | 0.180 |
Why?
|
| Microtubules | 3 | 2013 | 1079 | 0.180 |
Why?
|
| Green Fluorescent Proteins | 6 | 2018 | 2051 | 0.180 |
Why?
|
| Freezing | 4 | 2009 | 299 | 0.180 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2018 | 1078 | 0.180 |
Why?
|
| Chromosome Mapping | 1 | 2008 | 4628 | 0.180 |
Why?
|
| Stress, Mechanical | 2 | 2018 | 1661 | 0.170 |
Why?
|
| Organ Transplantation | 2 | 2021 | 1133 | 0.170 |
Why?
|
| Complement C3 | 1 | 2021 | 449 | 0.170 |
Why?
|
| Time Factors | 16 | 2016 | 39846 | 0.170 |
Why?
|
| Models, Theoretical | 6 | 2020 | 3546 | 0.170 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 2020 | 170 | 0.170 |
Why?
|
| Helicobacter pylori | 1 | 2022 | 373 | 0.160 |
Why?
|
| Stochastic Processes | 2 | 2010 | 352 | 0.160 |
Why?
|
| Adenine | 1 | 2024 | 977 | 0.160 |
Why?
|
| Toll-Like Receptors | 1 | 2022 | 591 | 0.160 |
Why?
|
| Coculture Techniques | 2 | 2021 | 1333 | 0.160 |
Why?
|
| Biosensing Techniques | 1 | 2005 | 670 | 0.160 |
Why?
|
| Mouth | 1 | 2021 | 376 | 0.150 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2020 | 2476 | 0.150 |
Why?
|
| Mycoses | 1 | 2021 | 383 | 0.150 |
Why?
|
| Leukocyte Elastase | 1 | 2018 | 114 | 0.150 |
Why?
|
| Immunity | 2 | 2021 | 993 | 0.150 |
Why?
|
| Phenotype | 4 | 2024 | 16443 | 0.150 |
Why?
|
| Neural Stem Cells | 2 | 2018 | 876 | 0.150 |
Why?
|
| Microtechnology | 1 | 2018 | 70 | 0.150 |
Why?
|
| Critical Illness | 3 | 2018 | 2685 | 0.150 |
Why?
|
| Laboratory Animal Science | 1 | 2017 | 9 | 0.150 |
Why?
|
| Chromatin | 2 | 2022 | 2916 | 0.150 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2020 | 620 | 0.150 |
Why?
|
| Wound Healing | 4 | 2012 | 2773 | 0.140 |
Why?
|
| Cell Tracking | 1 | 2018 | 140 | 0.140 |
Why?
|
| Species Specificity | 1 | 2021 | 2404 | 0.140 |
Why?
|
| Glutamate Decarboxylase | 1 | 2018 | 239 | 0.140 |
Why?
|
| Molecular Chaperones | 2 | 2014 | 743 | 0.140 |
Why?
|
| Peroxidase | 1 | 2020 | 601 | 0.140 |
Why?
|
| Carrier Proteins | 2 | 2023 | 4931 | 0.140 |
Why?
|
| Chemokine CXCL10 | 2 | 2015 | 315 | 0.140 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2018 | 371 | 0.140 |
Why?
|
| Neutropenia | 1 | 2022 | 882 | 0.140 |
Why?
|
| Pseudomonas Infections | 1 | 2021 | 618 | 0.140 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2020 | 882 | 0.140 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2021 | 1255 | 0.140 |
Why?
|
| Young Adult | 11 | 2021 | 57632 | 0.140 |
Why?
|
| Mice | 24 | 2022 | 80550 | 0.140 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2015 | 1793 | 0.140 |
Why?
|
| Ficoll | 1 | 2016 | 39 | 0.130 |
Why?
|
| Cell Survival | 5 | 2017 | 5771 | 0.130 |
Why?
|
| Silicones | 1 | 2017 | 227 | 0.130 |
Why?
|
| Succinimides | 1 | 2015 | 78 | 0.130 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2016 | 132 | 0.130 |
Why?
|
| Cell Membrane Permeability | 1 | 2017 | 575 | 0.130 |
Why?
|
| Cell Adhesion | 4 | 2014 | 3088 | 0.130 |
Why?
|
| Piperidines | 1 | 2024 | 1645 | 0.130 |
Why?
|
| Biophysical Phenomena | 2 | 2009 | 320 | 0.120 |
Why?
|
| Chemokine CCL5 | 1 | 2015 | 214 | 0.120 |
Why?
|
| Disease Models, Animal | 8 | 2018 | 17958 | 0.120 |
Why?
|
| Median Eminence | 1 | 2014 | 28 | 0.120 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2015 | 221 | 0.120 |
Why?
|
| Prostaglandins | 1 | 2015 | 396 | 0.120 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2018 | 572 | 0.120 |
Why?
|
| Anti-Bacterial Agents | 3 | 2019 | 7295 | 0.120 |
Why?
|
| Liver Function Tests | 1 | 2016 | 524 | 0.120 |
Why?
|
| Cromolyn Sodium | 1 | 2014 | 82 | 0.120 |
Why?
|
| Leukotrienes | 1 | 2015 | 233 | 0.120 |
Why?
|
| Confined Spaces | 1 | 2014 | 10 | 0.120 |
Why?
|
| Chemokine CXCL12 | 2 | 2014 | 453 | 0.120 |
Why?
|
| Cyclic N-Oxides | 1 | 2014 | 72 | 0.120 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2018 | 1897 | 0.120 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2016 | 4279 | 0.110 |
Why?
|
| Male | 28 | 2021 | 354908 | 0.110 |
Why?
|
| Kidney Function Tests | 1 | 2016 | 676 | 0.110 |
Why?
|
| Cell Count | 2 | 2016 | 1832 | 0.110 |
Why?
|
| Blood Coagulation | 1 | 2020 | 1149 | 0.110 |
Why?
|
| Thrombocytopenia | 1 | 2022 | 1170 | 0.110 |
Why?
|
| Genes, Reporter | 1 | 2018 | 1531 | 0.110 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2021 | 1820 | 0.110 |
Why?
|
| Neoplastic Stem Cells | 2 | 2020 | 1341 | 0.110 |
Why?
|
| Cell Nucleolus | 1 | 2014 | 157 | 0.110 |
Why?
|
| Cell Differentiation | 4 | 2021 | 11425 | 0.110 |
Why?
|
| Adult | 16 | 2021 | 216927 | 0.110 |
Why?
|
| rho GTP-Binding Proteins | 2 | 2013 | 280 | 0.110 |
Why?
|
| Microvessels | 2 | 2015 | 571 | 0.110 |
Why?
|
| Chemokines | 1 | 2018 | 957 | 0.110 |
Why?
|
| Nerve Growth Factors | 1 | 2016 | 561 | 0.110 |
Why?
|
| Coloring Agents | 1 | 2016 | 556 | 0.110 |
Why?
|
| Antigens | 2 | 2015 | 1439 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2018 | 1248 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2024 | 8422 | 0.110 |
Why?
|
| Stem Cell Transplantation | 1 | 2021 | 1600 | 0.110 |
Why?
|
| Hydrodynamics | 1 | 2013 | 162 | 0.110 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2012 | 54 | 0.100 |
Why?
|
| Pancreatic Elastase | 1 | 2012 | 129 | 0.100 |
Why?
|
| Golgi Apparatus | 1 | 2014 | 400 | 0.100 |
Why?
|
| Dynamins | 1 | 2013 | 139 | 0.100 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2018 | 896 | 0.100 |
Why?
|
| Microscopy, Phase-Contrast | 2 | 2009 | 111 | 0.100 |
Why?
|
| Spin Labels | 1 | 2014 | 335 | 0.100 |
Why?
|
| Laminin | 1 | 2014 | 403 | 0.100 |
Why?
|
| Lymphocyte Count | 1 | 2014 | 776 | 0.100 |
Why?
|
| Myosin Light Chains | 2 | 2022 | 121 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 7 | 2016 | 21717 | 0.100 |
Why?
|
| Anisotropy | 1 | 2015 | 1286 | 0.100 |
Why?
|
| Calibration | 2 | 2004 | 806 | 0.100 |
Why?
|
| Monitoring, Physiologic | 1 | 2019 | 1760 | 0.100 |
Why?
|
| Point-of-Care Systems | 2 | 2011 | 1183 | 0.100 |
Why?
|
| Microchip Analytical Procedures | 1 | 2011 | 29 | 0.100 |
Why?
|
| Micro-Electrical-Mechanical Systems | 1 | 2011 | 31 | 0.100 |
Why?
|
| Biological Transport, Active | 1 | 2012 | 329 | 0.100 |
Why?
|
| Cystic Fibrosis | 1 | 2021 | 1261 | 0.100 |
Why?
|
| Random Allocation | 1 | 2016 | 2387 | 0.100 |
Why?
|
| Immunocompromised Host | 1 | 2017 | 854 | 0.100 |
Why?
|
| HIV Seropositivity | 2 | 2007 | 954 | 0.100 |
Why?
|
| Equipment Failure Analysis | 2 | 2016 | 846 | 0.090 |
Why?
|
| Temperature | 4 | 2009 | 2197 | 0.090 |
Why?
|
| Mycobacterium smegmatis | 1 | 2011 | 123 | 0.090 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2020 | 8933 | 0.090 |
Why?
|
| CD4 Lymphocyte Count | 2 | 2007 | 2556 | 0.090 |
Why?
|
| Mice, Transgenic | 7 | 2021 | 9467 | 0.090 |
Why?
|
| Proteoglycans | 1 | 2014 | 802 | 0.090 |
Why?
|
| Pressure | 1 | 2013 | 1148 | 0.090 |
Why?
|
| Liver Cirrhosis | 1 | 2021 | 1892 | 0.090 |
Why?
|
| Neurodegenerative Diseases | 1 | 2019 | 1065 | 0.090 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2010 | 203 | 0.090 |
Why?
|
| Chemokine CCL2 | 1 | 2013 | 597 | 0.090 |
Why?
|
| Receptors, CXCR3 | 1 | 2011 | 234 | 0.090 |
Why?
|
| Lymphocytes | 1 | 2018 | 2592 | 0.090 |
Why?
|
| Thrombosis | 2 | 2016 | 3018 | 0.090 |
Why?
|
| Cell Migration Inhibition | 2 | 2008 | 97 | 0.090 |
Why?
|
| Particle Size | 3 | 2008 | 1633 | 0.090 |
Why?
|
| GTP Phosphohydrolases | 1 | 2013 | 507 | 0.090 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2018 | 2868 | 0.090 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2023 | 4495 | 0.090 |
Why?
|
| Nocodazole | 1 | 2009 | 95 | 0.090 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2010 | 118 | 0.090 |
Why?
|
| Eukaryota | 1 | 2010 | 100 | 0.090 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 3106 | 0.080 |
Why?
|
| Lymph Nodes | 1 | 2021 | 3474 | 0.080 |
Why?
|
| Kinetics | 4 | 2009 | 6352 | 0.080 |
Why?
|
| Surface Properties | 2 | 2009 | 1154 | 0.080 |
Why?
|
| Cell Nucleus | 1 | 2018 | 2905 | 0.080 |
Why?
|
|